Here are the 10-Q quarterly reports from Bespoke Extracts Inc (BSPK) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow BSPK and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BSPK filings page.
Bespoke Extracts, Inc. reported Q3 2025 results with stronger sales but continued losses and liquidity pressure. Sales were $467,945 (up from $277,471), generating gross profit of $234,175. Operating loss narrowed to $53,891, and net loss was $78,088 or $0.01 per share.
For the first nine months, sales reached $1,121,657 with gross profit of $542,453 and a net loss of $543,715. Operating expenses declined year over year as stock-based compensation fell, partly offset by higher salaries.
Liquidity remains constrained: cash was $16,743, current liabilities were $1,872,581, and the company reported a working capital deficit of $1,675,749 and a stockholders’ deficit of $2,595,508. Management disclosed “substantial doubt” about the ability to continue as a going concern. Debt includes 15% Senior Secured Notes and a related‑party note of $849,500 (maturity extended to June 30, 2027 after quarter‑end). The company also reported material weaknesses in disclosure controls.